Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Georgetown University Medical Center
Research
Once-failed cancer drug ramps up I-O in pancreatic cancer models
BioXcel's DPP inhibitor talabostat combined with a PD-1 blocker increased the recruitment of immune cells in mouse models of pancreatic cancer.
Arlene Weintraub
Nov 8, 2021 10:00am
Targeting 'enabler cells' in triple-negative breast cancer
Jun 17, 2021 9:45am
How Novartis' Tasigna restores dopamine in Parkinson's disease
Dec 16, 2019 11:00am
Repurposing Pfizer's heart rhythm drug Tikosyn to treat PAH
Dec 12, 2019 8:45am
Repurposing Novartis’ cancer drug Tasigna in Parkinson’s
Mar 13, 2019 11:23am
Natural protein curbs obesity in mice
Oct 29, 2018 5:00am
